MEDVi Review 2026: The Lowest Entry Price, and What Comes With It
MEDVi gets attention for one reason. Its compounded semaglutide starts at $179 for the first month, which undercuts nearly every competitor in cash-pay GLP-1 telehealth. That price is […]
MEDVi gets attention for one reason. Its compounded semaglutide starts at $179 for the first month, which undercuts nearly every competitor in cash-pay GLP-1 telehealth.
That price is real, and so is the rest of the offering: 24/7 clinician access, free shipping to all 50 states, no membership fee, and prescriptions typically issued within two days.
This review covers what you get for the money, and the handful of things worth checking before you enroll.
Medical disclaimer: This article is educational and is not medical advice. GLP-1 medications are prescription treatments. Only a licensed clinician can determine whether they are appropriate for you.
What MEDVi Is
MEDVi is a Delaware-based telehealth platform offering compounded semaglutide and tirzepatide, plus brand-name options, to cash-paying patients across all 50 states. It is LegitScript certified, which verifies it as an operating, compliant telehealth business.
Intake is asynchronous. You complete a medical history form and submit photo ID plus height and weight, and a licensed clinician reviews it rather than meeting you live. Average time to a first prescription is around two days, which is fast for this category.
There is no separate membership fee, and cancellation is month-to-month with no penalty.
What It Costs
| Item | Price | Notes |
|---|---|---|
| Compounded semaglutide, first month | From $179 | Entry pricing, the lowest in the category |
| Compounded semaglutide, ongoing | Around $297 to $299 | Flat monthly rate reported by multiple sources |
| Compounded tirzepatide | Around $299 | Flat monthly rate |
| Shipping | Included | Free delivery to all 50 states |
| Membership fee | None | Medication price covers the program |
For context, brand-name Wegovy and Zepbound commonly run $1,300 to $1,500 a month without insurance coverage.
One thing to watch: the first-month price and the ongoing price are different numbers. Budget from the ongoing rate, not the introductory one.
One Regulatory Note
In February 2026, the FDA issued a warning letter to MEDVi concerning how its website described its compounded products, specifically language that implied FDA approval and suggested MEDVi was the compounder rather than its partner pharmacy.
Importantly, the letter addressed marketing and labeling wording, not medication safety, and the FDA has increased scrutiny across the entire compounded GLP-1 sector as brand-name shortages eased. It is context worth having, not a reason on its own to rule the platform out.
What Compounded Actually Means
Compounded medications are prepared by compounding pharmacies rather than the original manufacturer. They are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality.
Section 503A of the Federal Food, Drug, and Cosmetic Act allows compounding for individual patient needs when a commercial product is unavailable or unsuitable. That served a genuine purpose during the GLP-1 shortages of 2023 to 2025.
The active ingredients themselves have strong evidence behind them. Semaglutide was studied in the STEP trials and tirzepatide in the SURMOUNT trials, both published in the New England Journal of Medicine. But those trials tested brand-name formulations. Compounded versions have no equivalent clinical trial data, and that distinction is the whole point.
Ask directly which pharmacy compounds your medication and whether it is a 503A or 503B facility. A platform that answers clearly is telling you something useful.
Why Members Choose MEDVi
Round-the-clock clinician access. MEDVi provides 24/7 access to licensed providers, with optional same-day visits.
Speed. A short eligibility quiz, asynchronous clinician review, and an average of about two days to a first prescription.
Flat pricing. Your rate does not climb as your dose increases, and there is no separate membership fee. Reported member feedback also notes an absence of supplement upsells at checkout.
Choice of format. Both injectable and oral options are available, which matters for anyone uneasy about self-injection.
No lock-in. Month-to-month cancellation with no fee, and free delivery to all 50 states.
LegitScript certification. An independent verification that a telehealth business meets legal and regulatory operating standards.
Trustpilot ratings for the platform sit around 4.5 out of 5.
Before You Start
A short practical checklist for your provider review. GLP-1 medications commonly cause digestive side effects when starting or increasing a dose, so ask what to expect and how to manage it. Share your full medical history, including any thyroid conditions, pancreatitis, gallbladder issues, or history of disordered eating, and mention if you are pregnant or breastfeeding. Because intake here is asynchronous, note how to reach a clinician before you start rather than after a question comes up.
Whom MEDVi Suits
MEDVi may work if cost is your primary constraint, you want fast access without a live appointment, and you are comfortable monitoring your own billing closely.
It is a poor fit if you want regular clinical contact during titration, you are uneasy about an unresolved regulatory issue, or this is your first time on any GLP-1 and you would benefit from more hands-on supervision.
Frequently Asked Questions
Is MEDVi legitimate?
Yes. It is a LegitScript-certified telehealth company operating in all 50 states with licensed clinicians and named partner pharmacies.
How much does MEDVi cost?
Compounded semaglutide starts around $179 for the first month, with ongoing pricing reported around $297 to $299. Tirzepatide runs about $299 monthly. Shipping is included.
Did the FDA say the medication is unsafe?
No. The warning letter addressed website language and labeling, specifically claims implying FDA approval and implying MEDVi was the compounder. It did not make a finding about medication safety.
Is there a live doctor visit?
Not by default. Intake is asynchronous, meaning a licensed clinician reviews your submitted information rather than meeting you in real time.
Are compounded GLP-1s the same as Wegovy?
No. They contain the same active ingredient but are not FDA-approved products and have no equivalent clinical trial data.
The Verdict
MEDVi delivers what it advertises on price. For anyone priced out of brand-name GLP-1s, the entry cost is among the lowest available anywhere, and the process from quiz to prescription is genuinely fast.
What makes it more than a budget option is the combination around that price: 24/7 clinician access, both oral and injectable formats, flat rates that do not climb with your dose, free shipping nationwide, and no contract holding you in place. Trustpilot ratings sit around 4.5 out of 5.
Before enrolling, ask which pharmacy compounds your medication, note how to reach a clinician quickly, and budget from the ongoing rate rather than the introductory one. As with any prescription decision, the conversation that matters most is the one with a clinician who knows your medical history.